167 related articles for article (PubMed ID: 26353928)
1. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.
Pandyra AA; Mullen PJ; Goard CA; Ericson E; Sharma P; Kalkat M; Yu R; Pong JT; Brown KR; Hart T; Gebbia M; Lang KS; Giaever G; Nislow C; Moffat J; Penn LZ
Oncotarget; 2015 Sep; 6(29):26909-21. PubMed ID: 26353928
[TBL] [Abstract][Full Text] [Related]
2. The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.
Walsh CA; Akrap N; Garre E; Magnusson Y; Harrison H; Andersson D; Jonasson E; Rafnsdottir S; Choudhry H; Buffa F; Ragoussis J; Ståhlberg A; Harris A; Landberg G
PLoS One; 2020; 15(7):e0236187. PubMed ID: 32692762
[TBL] [Abstract][Full Text] [Related]
3. Overcoming statin resistance in prostate cancer cells by targeting the 3-hydroxy-3-methylglutaryl-CoA-reductase.
Göbel A; Pählig S; Motz A; Breining D; Traikov S; Hofbauer LC; Rachner TD
Biochem Biophys Res Commun; 2024 May; 710():149841. PubMed ID: 38588613
[TBL] [Abstract][Full Text] [Related]
4. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
Kaymak I; Maier CR; Schmitz W; Campbell AD; Dankworth B; Ade CP; Walz S; Paauwe M; Kalogirou C; Marouf H; Rosenfeldt MT; Gay DM; McGregor GH; Sansom OJ; Schulze A
Cancer Res; 2020 Jan; 80(2):189-203. PubMed ID: 31744820
[TBL] [Abstract][Full Text] [Related]
5. Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation.
Dos Santos DZ; Elbaz M; Branchard E; Schormann W; Brown CE; Meek AR; Njar VCO; Hamilton RJ; Reed MA; Andrews DW; Penn LZ
Biomed Pharmacother; 2024 Jun; 177():116934. PubMed ID: 38889639
[TBL] [Abstract][Full Text] [Related]
6. Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study.
Gray RT; Loughrey MB; Bankhead P; Cardwell CR; McQuaid S; O'Neill RF; Arthur K; Bingham V; McGready C; Gavin AT; James JA; Hamilton PW; Salto-Tellez M; Murray LJ; Coleman HG
Br J Cancer; 2017 Jun; 116(12):1652-1659. PubMed ID: 28524155
[TBL] [Abstract][Full Text] [Related]
7. The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway.
Pampalakis G; Obasuyi O; Papadodima O; Chatziioannou A; Zoumpourlis V; Sotiropoulou G
Oncotarget; 2014 May; 5(9):2390-403. PubMed ID: 24158494
[TBL] [Abstract][Full Text] [Related]
8. p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells.
Centonze G; Natalini D; Grasso S; Morellato A; Salemme V; Piccolantonio A; D'Attanasio G; Savino A; Bianciotto OT; Fragomeni M; Scavuzzo A; Poncina M; Nigrelli F; De Gregorio M; Poli V; Arina P; Taverna D; Kopecka J; Dupont S; Turco E; Riganti C; Defilippi P
Cell Death Dis; 2023 Dec; 14(12):849. PubMed ID: 38123597
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-hydrolyzing phosphodiesterase inhibitors potentiate statin-induced cancer cell death.
Longo J; Pandyra AA; Stachura P; Minden MD; Schimmer AD; Penn LZ
Mol Oncol; 2020 Oct; 14(10):2533-2545. PubMed ID: 32749766
[TBL] [Abstract][Full Text] [Related]
10. Expression of 3-hydroxy-3-methylglutaryl-CoA reductase, p-hydroxybenzoate-m-geranyltransferase and genes of phenylpropanoid pathway exhibits positive correlation with shikonins content in arnebia [Arnebia euchroma (Royle) Johnston].
Singh RS; Gara RK; Bhardwaj PK; Kaachra A; Malik S; Kumar R; Sharma M; Ahuja PS; Kumar S
BMC Mol Biol; 2010 Nov; 11():88. PubMed ID: 21092138
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin-Dipyridamole Combination Treatment in Melanoma Cell Lines.
Irie N; Mizoguchi K; Warita T; Nakano M; Sasaki K; Tashiro J; Osaki T; Ishikawa T; Oltvai ZN; Warita K
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540310
[TBL] [Abstract][Full Text] [Related]
12. Statins as anti-tumor agents: A paradigm for repurposed drugs.
Tripathi S; Gupta E; Galande S
Cancer Rep (Hoboken); 2024 May; 7(5):e2078. PubMed ID: 38711272
[TBL] [Abstract][Full Text] [Related]
13. In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency.
Kubota CS; Myers SL; Seppälä TT; Burkhart RA; Espenshade PJ
bioRxiv; 2024 May; ():. PubMed ID: 38746286
[TBL] [Abstract][Full Text] [Related]
14. The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
Erkner E; Hentrich T; Schairer R; Fitzel R; Secker-Grob KA; Jeong J; Keppeler H; Korkmaz F; Schulze-Hentrich JM; Lengerke C; Schneidawind D; Schneidawind C
Oncogene; 2024 Jan; 43(4):281-293. PubMed ID: 38030791
[TBL] [Abstract][Full Text] [Related]
15. The role of oxysterol binding protein-related protein 5 in pancreatic cancer.
Ishikawa S; Nagai Y; Masuda T; Koga Y; Nakamura T; Imamura Y; Takamori H; Hirota M; Funakosi A; Fukushima M; Baba H
Cancer Sci; 2010 Apr; 101(4):898-905. PubMed ID: 20128820
[TBL] [Abstract][Full Text] [Related]
16. Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma.
Wei M; Nurjanah U; Herkilini A; Huang C; Li Y; Miyagishi M; Wu S; Kasim V
Cell Mol Life Sci; 2022 Aug; 79(9):472. PubMed ID: 35933495
[TBL] [Abstract][Full Text] [Related]
17. Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response.
Xiao MY; Pei WJ; Li S; Li FF; Xie P; Luo HT; Hyun Yoo H; Piao XL
Bioorg Chem; 2024 Jun; 150():107539. PubMed ID: 38861912
[TBL] [Abstract][Full Text] [Related]
18. Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics.
Ishikawa T; Hosaka YZ; Beckwitt C; Wells A; Oltvai ZN; Warita K
Oncotarget; 2018 Jun; 9(50):29304-29315. PubMed ID: 30034619
[TBL] [Abstract][Full Text] [Related]
19. Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role.
Marcianò G; Palleria C; Casarella A; Rania V; Basile E; Catarisano L; Vocca C; Bianco L; Pelaia C; Cione E; D'Agostino B; Citraro R; De Sarro G; Gallelli L
Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631415
[TBL] [Abstract][Full Text] [Related]
20. Nanoemulsion and Encapsulation Strategy of Hydrophobic Oregano Essential Oil Increased Human Prostate Cancer Cell Death via Apoptosis by Attenuating Lipid Metabolism.
Perumalsamy H; Shanmugam R; Kim JR; Anandapadmanaban G; Huq MA; Dua K; Chellappan DK; Yoon TH; Balusamy SR
Bioinorg Chem Appl; 2022; 2022():9569226. PubMed ID: 35662912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
